... 擇之一。今日介紹山東新華製藥(00719),10月衝刺一輪後整個11月都在調整,現價位已到入市時機。 藥股轉強 ...全文
... 中尋找領導股。 山東新華製藥(00719)上月發盈喜,預期今年中期盈利按年增長1倍至1.5倍,即盈利介乎920 ...全文
... 醫藥(03320)、新華製藥(00719)及東瑞藥業(02348)。上周亦提及一眾礦業資產股偏強,無論是鞍鋼( ...全文
... 加11.22%;山東新華製藥股份(00719)今年首9個月,純利8918萬元,折合約一億港元,按年升44.35 ...全文
A slew of bad news hit the market recently, but it may turn out to be good news for Hong Kong equities. The massive fines faced by Deutsche Bank and the possibility of a hard Brexit are increasing glo ...More
EJ Insight2016-10-11
... (00042)、山東新華製藥(00719)、海信科龍(00921)、浙江世寶(01057)、濰柴動力(0233 ...全文
Hong Kong market has benefited this month from capital inflows as some investors withdrew money from Europe and returned to Asia. But the outlook for the next few months is hazy as it is uncertain wh ...More
EJ Insight2016-07-26
Brexit vote has triggered huge volatility in global financial markets, giving anxious moments to investors. While trading will remain choppy in the near term, the chaos stemming from the UK referendu ...More
EJ Insight2016-06-29
China’s A-share market may face downward correction risk in the short term given that authorities are looking for a well-supported bull market instead of a relentless crazy bull, which goes against th ...More
EJ Insight2015-01-06
Hong Kong stocks closed lower Tuesday, tracking losses by their mainland counterparts. The benchmark Hang Seng Index slipped 71 points, or 0.32 percent, to 22,317. The Hang Seng China Enterprises Inde ...More
EJ Insight2014-02-25